SONAR: Do a New Design and Statistically Significant Results Translate to Reliability?

被引：4

作者：

Walsh, Michael ^{[1
,2
]}

机构：

[1] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada

[2] McMaster Univ, Hamilton, ON, Canada

来源：

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2020年 / 15卷 / 06期

关键词：

atrasentan; randomized controlled trials; diabetic nephropathy; humans; albuminuria; diabetic nephropathies; endothelin A receptor antagonists; type 2 diabetes mellitus; creatinine; nephrology; incidence; confidence intervals; endothelin A receptor; sample size; reproducibility of results; pyrrolidines; chronic renal insufficiency; chronic kidney failure; kidney;

D O I：

10.2215/CJN.08540719

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：889 / 891

页数：3